Maria Teresa S. M.
- Country
- Spain
- Department
- Neurology
Research Overview
- Long-term Evaluation of Safety, Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Empasiprubart in Adults with Multifocal Motor Neuropathy
- Pharmacokinetic Comparability Study of TAK-881 and Human Normal Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients
- A Phase 2b, Multi-center, Randomized, Double-blind, Placebo controlled Study of IMVT-1402 Treatment in Adult Participants with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Data & Insights
Has run more than one trial at 34 of 108 partner sites.
Specializations
Neurological Disorders
This investigator specializes in the study of chronic inflammatory demyelinating polyneuropathy (CIDP), focusing on developing innovative therapeutic approaches for this rare neurological condition.
- Autoimmune Neuropathies
- Peripheral Nervous System Disorders
- Neuroimmunology
Their research involves evaluating novel therapeutic agents for patients with inflammatory neuropathies.
Treatment Development
The investigator's work centers on advancing treatment options for autoimmune disorders affecting the peripheral nervous system.
- Novel Therapeutics
- Safety Assessment
- Clinical Efficacy
Their expertise extends to evaluating the tolerability of emerging treatments in neurological conditions.
Clinical Assessment
Specializing in therapeutic evaluation methods for neurological disorders, with particular emphasis on safety monitoring and patient outcomes.
- Treatment Response Assessment
- Patient Safety Monitoring
- Clinical Outcomes
Their research focuses on developing comprehensive assessment protocols for neurological treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.